TrialClinical and translational science2021

Pharmacokinetic equivalence of CT-P17 to high-concentration (100 mg/ml) reference adalimumab: A randomized phase I study in healthy subjects.

Kyung-Sang Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.